服務(wù)承諾：工作時間內(nèi)提供免費的技術(shù)咨詢和指導(dǎo) 。我公司的技術(shù)人員都經(jīng)過專業(yè)培訓(xùn)的，將為您提供滿意的產(chǎn)品和真誠的服務(wù)。

偶氮胭脂紅G 號：25641-18-3  
英文名稱：Azocarmine G；Rosinduline GXF；Rosazine；Rosinduline；N-Phenylrosinduline sulfonic acid disodium salt；

C.I.50085   
其他名稱：酸性紅101；偶氮洋紅G；玫紅對氮蒽；偶氮紅G；羅星杜林；玫紅杜林   
號：25641-18-3   
C28H18N3NaO6S2=579.58   
級別：BS   
鑒別：合格   
λmax：523～526nm (H2O)   
性狀(以下信息僅供參考)：帶金黃色光澤的紅色或棕色或紫色粉末。微溶于水,溶液呈藍紅色。   
用途：本品僅供科研，不得用于其它用途。(以下用途僅供參考)組織染色。氧化還原指示劑。   
保存：RT

客戶根據(jù)偶氮胭脂紅G 號：25641-18-3性質(zhì)、化學(xué)式、分子式、結(jié)構(gòu)式、比重、密度、號、沸點、熔點、水溶性、MSDS、用途、作用、規(guī)格包裝、性狀、注意事項、英文名、別稱、純度、級別等情況，本產(chǎn)品化學(xué)性質(zhì)穩(wěn)定，運輸條件不苛刻，一般儲存在陰涼，干燥，通風(fēng)良好的地方，遠離不相容的物質(zhì)。保持容器密閉。
試劑品牌：TCI、sigma、Alfa、Avocado、Aldrich、ACROS、Fluka、ICN（MP）等
包裝：1kg、100g、10g、250g、25g、500g、50g、5g等包裝
級別：GR級別、AR級別、CP級別、L.P.級別等
公司提供的偶氮胭脂紅G 號：25641-18-3*，貨源充足。嚴格的生產(chǎn)質(zhì)量控制體系，包括：優(yōu)級純，分析純，化學(xué)純，試劑級，基準試劑，實驗純，教學(xué)試劑，高純試劑，色譜純，光譜純，電子純。各種包裝規(guī)格，并可提供包裝定制，咨詢訂購。

購買須知：
【價格方面】
每個時期原料的價格都會波動，產(chǎn)品的價格會有所升降，以上報價僅為參考報價！咨詢選購！

【付款方式】
現(xiàn)金，支付寶，銀行轉(zhuǎn)帳，匯款，支票，本票；
請將款項匯至我司公司賬戶（開票的）或者老板的私人賬戶上面，接受支付寶付款；
我司收到款項后會根據(jù)客戶的相關(guān)要求盡快安排發(fā)貨！

【發(fā)貨時間】
物流基本上在下午2點之前提交確認的訂單，都將盡力安排當天發(fā)貨；
如果訂單產(chǎn)品需要拆分及其他特殊情況的要求，則可能會有一定的延時。

【配送方式】
確定的訂單后，小貨我司將通過順豐、韻達等快遞送達；
大量貨物會更具情況以德邦、遠成，普華，中鐵等物流的運輸方式發(fā)貨。

【其他服務(wù)】
如您對產(chǎn)品特性及技術(shù)指標有特殊要求，我公司可以提供質(zhì)檢單和相關(guān)產(chǎn)品的資料和文件；
如果對產(chǎn)品的包裝或者分裝的有要求的話，也請及時通知我方，我方好根據(jù)要求盡量滿足您的所需求。

【服務(wù)宗旨】
竭誠提供優(yōu)質(zhì)產(chǎn)品，售后服務(wù)客戶滿意度100％

DISEASE : Neurofibromatosis 1 (NF1) [MIM:162200]: A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors. Note=The disease is caused by mutations affecting the gene represented in this entry.
Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The disease is caused by mutations affecting the gene represented in this entry.
Watson syndrome (WS) [MIM:193520]: A syndrome characterized by the presence of pulmonary stenosis, cafe-au-lait spots, and mental retardation. It is considered as an atypical form of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry.
Familial spinal neurofibromatosis (FSNF) [MIM:162210]: Considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors. Note=The disease is caused by mutations affecting the gene represented in this entry.
Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]: Characterized by manifestations of both NF1 and Noonan syndrome (NS). NS is a disorder characterized by dysmorphic facial features, short stature, hyperorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. Note=The disease is caused by mutations affecting the gene represented in this entry.
Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.
Similarity : Contains 1 CRAL-TRIO domain.
Contains 1 Ras-GAP domain.
Database links : UniProtKB/Swiss-Prot: P21359.2
英文名稱  Anti-Phospho-NFKB1(Ser373)
偶氮胭脂紅G 號：25641-18-3中文名稱  磷酸化細胞核因子p50/k基因結(jié)合核因子抗體
別    名  Phospho-NFKB1(Ser373); NFKB1(phospho S373); NF kappa B; NFKB 1; NFKB p105; NFKB p50; NFKB1; Nuclear factor kappa B DNA binding subunit; Nuclear factor NF kappa B p105 subunit; Nuclear factor NF kappa B p50 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 1; DKFZp686C01211; DNA binding factor KBF1; DNA binding factor KBF1 EBP1; EBP 1; EBP1; KBF1; MGC54151; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; Nfkb1; NF-kappaB; NF-kappaB1; NF-KB1; p105; p50; p50/p105; DKFZp686C01211; EBP-1; KBF1; MGC54151; Nf kappa b DNA binding subunit; NF-KAPPAB; NF-KAPPAB1; NFKB; NFKB SUBUNIT P105/P50; NFKB-p105; NFKB1; NUCLEAR FACTOR KAPPA B DNA BINDING SUBUNIT; p105 Nfkb;p50 NF-kappa B;p50NFKB.
濃    度  1mg/1ml
規(guī) 格  0.1ml/100μg
抗體來源  Rabbit 
克隆類型  polyclonal
交叉反應(yīng)  Human, Mouse, Rat, Pig, Cow, Horse, Sheep
產(chǎn)品類型  一抗  磷酸化抗體  
研究領(lǐng)域  腫瘤 細胞生物 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 細胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶 
蛋白分子量  predicted molecular weight: 105kDa
性    狀  Lyophilized or Liquid